166 related articles for article (PubMed ID: 38514488)
21. LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.
Wang J; Zhao H; Dong H; Zhu L; Wang S; Wang P; Ren Q; Zhu H; Chen J; Lin Z; Cheng Y; Qian B; Zhang Y; Jia R; Wu W; Lu J; Tan J
J Cancer; 2019; 10(26):6726-6737. PubMed ID: 31777602
[No Abstract] [Full Text] [Related]
22. Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data.
Qin XG; Zeng JH; Lin P; Mo WJ; Li Q; Feng ZB; Luo DZ; Yang H; Chen G; Zeng JJ
Pathol Res Pract; 2019 Mar; 215(3):414-426. PubMed ID: 30455130
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3.
Dai YC; Pan Y; Quan MM; Chen Q; Pan Y; Ruan YY; Sun JG
Front Oncol; 2021; 11():677168. PubMed ID: 34926237
[TBL] [Abstract][Full Text] [Related]
24. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
[TBL] [Abstract][Full Text] [Related]
25. NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β‑catenin pathway.
Ren Y; Wang Y; Hao S; Yang Y; Xiong W; Qiu L; Tao J; Tang A
J Cancer; 2020; 11(23):6939-6949. PubMed ID: 33123284
[No Abstract] [Full Text] [Related]
26. Prognostic significance of microRNA-135 in patients with digestive system cancers: a systematic review and meta-analysis.
Chao C; Sang C; Wang M; Wang Z; Li Y; Luo G; Zhang X
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31803920
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNAs in digestive system cancers: Functional roles, molecular mechanisms, and clinical implications (Review).
Fu M; Zou C; Pan L; Liang W; Qian H; Xu W; Jiang P; Zhang X
Oncol Rep; 2016 Sep; 36(3):1207-18. PubMed ID: 27431376
[TBL] [Abstract][Full Text] [Related]
28. RCAN1-4 is a thyroid cancer growth and metastasis suppressor.
Wang C; Saji M; Justiniano SE; Yusof AM; Zhang X; Yu L; Fernández S; Wakely P; La Perle K; Nakanishi H; Pohlman N; Ringel MD
JCI Insight; 2017 Mar; 2(5):e90651. PubMed ID: 28289712
[TBL] [Abstract][Full Text] [Related]
29. The prognostic significance of UCA1 for predicting clinical outcome in patients with digestive system malignancies.
Liu FT; Dong Q; Gao H; Zhu ZM
Oncotarget; 2017 Jun; 8(25):40620-40632. PubMed ID: 28380443
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.
Wu X; Wang S; Wang C; Wu C; Zhao Z
Sci Rep; 2024 Jan; 14(1):2468. PubMed ID: 38291086
[TBL] [Abstract][Full Text] [Related]
31. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Feng L; Li G; Li D; Duan G; Liu J
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA MALAT1 as a potential novel biomarker in digestive system cancers: a meta-analysis.
Song W; Zhang RJ; Zou SB
Minerva Med; 2016 Aug; 107(4):245-50. PubMed ID: 27348442
[TBL] [Abstract][Full Text] [Related]
33. Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation.
Chowdhury AMMA; Katoh H; Hatanaka A; Iwanari H; Nakamura N; Hamakubo T; Natsume T; Waku T; Kobayashi A
Sci Rep; 2017 Oct; 7(1):12494. PubMed ID: 28970512
[TBL] [Abstract][Full Text] [Related]
34. Nfe2l3 promotes neuroprotection and long-distance axon regeneration after injury in vivo.
Lukomska A; Frost MP; Theune WC; Xing J; Gupta M; Trakhtenberg EF
Exp Neurol; 2024 May; 375():114741. PubMed ID: 38395216
[TBL] [Abstract][Full Text] [Related]
35. Five hub genes contributing to the oncogenesis and trastuzumab-resistance in gastric cancer.
Chen F; Wang Y; Zhang X; Fang J
Gene; 2023 Jan; 851():146942. PubMed ID: 36202277
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Value and Immune Infiltration Analysis of Nuclear Factor Erythroid-2 Family Members in Ovarian Cancer.
Dou R; Wang X; Zhang J
Biomed Res Int; 2022; 2022():8672258. PubMed ID: 35059466
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel biomarkers, MUC5AC, MUC1, KRT7, GAPDH, CD44 for gastric cancer.
Yang J
Med Oncol; 2020 Mar; 37(5):34. PubMed ID: 32219571
[TBL] [Abstract][Full Text] [Related]
38. Appraising associations between signature lipidomic biomarkers and digestive system cancer risk: novel evidences from a prospective cohort study of UK Biobank and Mendelian randomization analyses.
Sun Y; Cao D; Zhang Y; Wu Y; Jia Z; Cui Y; Li D; Cao X; Jiang J
Lipids Health Dis; 2024 Feb; 23(1):61. PubMed ID: 38419059
[TBL] [Abstract][Full Text] [Related]
39. miR-23b-3p Inhibits the Oncogenicity of Colon Adenocarcinoma by Directly Targeting NFE2L3.
Huang G; Yang Y; Lv M; Huang T; Zhan X; Yao Y; Hou J
J Oncol; 2021; 2021():8493225. PubMed ID: 34966429
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of long noncoding RNA HOTAIR in digestive system malignancies.
Wang S; Wang Z
J Gastroenterol Hepatol; 2015 Jul; 30(7):1123-33. PubMed ID: 25754087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
